- Scheme Category:
- Equity Scheme >
- Sectoral/Thematic Funds
NAV: ₹ ↓ -0.12%
NAV chart
SMA (Simple Moving Average)
- 50 SMA
- 100 SMA
- 200 SMA
- 400 SMA
Returns
CAGR returns till date
CAGR returns of Tata India Pharma & Healthcare Fund-Direct Plan-Growth and its peers as on 21 August, 2026| Name | YTD | 1D | 1W | 1M | 3M | 1Y | 3Y | 5Y | 7Y | 10Y |
|---|---|---|---|---|---|---|---|---|---|---|
| Tata India Pharma & Healthcare Fund-Direct Plan-Growth | 12.49% | -0.12% | 0.03% | 0.75% | 6.33% | 9.32% | 20.22% | 15.48% | 23.33% | 15.14% |
| SBI CONSUMPTION OPPORTUNITIES FUND - DIRECT PLAN - GROWTH | -4.52% | -0.31% | -1.01% | 0.61% | 3.5% | -6.77% | 8.04% | 14.28% | 16.92% | 14.11% |
| SBI ESG Exclusionary Strategy Fund - Direct Plan -Growth | -1.66% | 0.07% | -0.07% | 0.97% | 5.68% | 1.7% | 11.14% | 10.16% | 14.05% | 12.13% |
| SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH | 23.27% | -0.4% | -0.88% | 1.43% | 9.85% | 19.12% | 24.15% | 19.25% | 26.46% | 15.04% |
| SBI INFRASTRUCTURE FUND - DIRECT PLAN - GROWTH | 2.72% | -0.03% | -1.43% | -1.99% | 0.11% | 4.99% | 15.77% | 18.42% | 20.37% | 15.3% |
| SBI COMMA Fund - DIRECT PLAN - Growth | 6.52% | -0.2% | -0.21% | 0.6% | 0.22% | 12.28% | 17.88% | 12.65% | 20.63% | 15.66% |
Discrete returns (yearly)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Returns | -12.74% | 5.85% | -0.68% | 7.04% | 67.87% | 19.94% | -6.85% | 39.53% | 42.49% | -3.93% |
Discrete returns (monthly)
| Month | Oct 2025 | Nov 2025 | Dec 2025 | Jan 2026 | Feb 2026 | Mar 2026 | Apr 2026 | May 2026 | Jun 2026 | Jul 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Returns | 1.74% | 0.22% | -1.64% | -5.6% | 4.93% | -6.3% | 6.93% | 3.25% | 4.52% | 4.39% |
Returns from spefic dates
| Description | CAGR returns from 18 Oct 2021 (Nifty 50 2021 high) | CAGR returns from 26 Sep 2024 (Nifty 50 2024 high) |
|---|---|---|
| Returns | 15.61% | 5.7% |
Portfolio
Asset allocation
| Equity | Debt | Realestate | Commodities | Cash & Equivalents |
|---|---|---|---|---|
| 99.13% | 0.00% (Arbitrage: 0.00%) | 0.00% | 0.00% | 0.87% |
Equity
| Name | Symbol / ISIN | Sector | Weight % |
|---|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES LTD | SUNPHARMA (INE044A01036) | Pharmaceuticals & Biotechnology | 8.59% |
| DIVI LABORATORIES LTD | DIVISLAB (INE361B01024) | Pharmaceuticals & Biotechnology | 6.36% |
| HEALTHCARE GLOBAL ENTERPRISES LTD | HCG (INE075I01017) | Healthcare Services | 5.85% |
| ABBOTT INDIA LTD | ABBOTINDIA (INE358A01014) | Pharmaceuticals & Biotechnology | 5.63% |
| RAINBOW CHILDRENS MEDICARE LTD | RAINBOW (INE961O01016) | Healthcare Services | 4.90% |
| GLAXOSMITHKLINE PHARMACEUTICALS LTD | GLAXO (INE159A01016) | Pharmaceuticals & Biotechnology | 4.66% |
| CIPLA LTD | CIPLA (INE059A01026) | Pharmaceuticals & Biotechnology | 4.53% |
| DR REDDYS LABORATORIES LTD | DRREDDY (INE089A01031) | Pharmaceuticals & Biotechnology | 4.25% |
| MAX HEALTHCARE INSTITUTE LTD | MAXHEALTH (INE027H01010) | Healthcare Services | 4.07% |
| APOLLO HOSPITALS ENTERPRISE LTD | APOLLOHOSP (INE437A01024) | Healthcare Services | 3.90% |
| BAYER CROPSCIENCE LTD | BAYERCROP (INE462A01022) | Fertilizers & Agrochemicals | 3.26% |
| FORTIS HEALTHCARE LTD | FORTIS (INE061F01013) | Healthcare Services | 3.12% |
| PFIZER LTD | PFIZER (INE182A01018) | Pharmaceuticals & Biotechnology | 3.06% |
| MANKIND PHARMA LTD | MANKIND (INE634S01028) | Pharmaceuticals & Biotechnology | 3.02% |
| SYNGENE INTERNATIONAL LTD | SYNGENE (INE398R01022) | Healthcare Services | 2.95% |
| SAI LIFE SCIENCES LTD | SAILIFE (INE570L01029) | Pharmaceuticals & Biotechnology | 2.89% |
| LUPIN LTD | LUPIN (INE326A01037) | Pharmaceuticals & Biotechnology | 2.64% |
| ALKEM LABORATORIES LTD | ALKEM (INE540L01014) | Pharmaceuticals & Biotechnology | 2.58% |
| PROCTER & GAMBLE HEALTH LTD | PGHL (INE199A01012) | Pharmaceuticals & Biotechnology | 2.42% |
| FDC LTD | FDC (INE258B01022) | Pharmaceuticals & Biotechnology | 2.39% |
| DR. LAL PATH LABS LTD | LALPATHLAB (INE600L01024) | Healthcare Services | 2.17% |
| GLOBAL HEALTH LTD | MEDANTA (INE474Q01031) | Healthcare Services | 2.13% |
| CONCORD BIOTECH LTD | CONCORDBIO (INE338H01029) | Pharmaceuticals & Biotechnology | 1.91% |
| SUMITOMO CHEMICAL INDIA LTD | SUMICHEM (INE258G01013) | Fertilizers & Agrochemicals | 1.59% |
| AJANTA PHARMA LTD | AJANTPHARM (INE031B01049) | Pharmaceuticals & Biotechnology | 1.53% |
| NEULAND LABORATORIES LTD | NEULANDLAB (INE794A01010) | Pharmaceuticals & Biotechnology | 1.25% |
| GILLETTE INDIA LTD | GILLETTE (INE322A01010) | Personal Products | 1.15% |
| METROPOLIS HEALTHCARE LTD | METROPOLIS (INE112L01020) | Healthcare Services | 1.12% |
| MANIPAL HEALTH ENTERPRISES LTD | (INE459N01021) | Healthcare Services | 0.97% |
| BASF INDIA LTD | BASF (INE373A01013) | Chemicals & Petrochemicals | 0.97% |
| JUBILANT PHARMOVA LTD | JUBLPHARMA (INE700A01033) | Pharmaceuticals & Biotechnology | 0.83% |
| DR. AGARWALS HEALTH CARE LTD | AGARWALEYE (INE943P01029) | Healthcare Services | 0.67% |
| SANOFI CONSUMER HEALTHCARE INDIA LTD | SANOFICONR (INE0UOS01011) | Pharmaceuticals & Biotechnology | 0.55% |
| BIOCON LTD | BIOCON (INE376G01013) | Pharmaceuticals & Biotechnology | 0.52% |
| ZIM LABORATORIES LTD | ZIMLAB (INE518E01015) | Pharmaceuticals & Biotechnology | 0.46% |
| SANOFI INDIA LTD | SANOFI (INE058A01010) | Pharmaceuticals & Biotechnology | 0.23% |
| ANTHEM BIOSCIENCES LTD | ANTHEM (INE0CZ201020) | Pharmaceuticals & Biotechnology | 0.01% |
Debt
| Name | Rating | Weight % |
|---|
Portfolio data is as on date 31 July, 2026
NAV history
Tata India Pharma & Healthcare Fund-Direct Plan-Growth - 30 days NAV (Net asset value) history
| Date | NAV | % change |
|---|---|---|
| 21 August, 2026 | 39.7376 | -0.12% |
| 20 August, 2026 | 39.7847 | -0.16% |
| 19 August, 2026 | 39.8493 | 0.19% |
| 18 August, 2026 | 39.7747 | 0.39% |
| 17 August, 2026 | 39.6203 | -0.26% |
| 14 August, 2026 | 39.7249 | -0.15% |
| 13 August, 2026 | 39.7848 | -0.4% |
| 12 August, 2026 | 39.9426 | -0.53% |
| 11 August, 2026 | 40.1562 | 0.25% |
| 10 August, 2026 | 40.0575 | 0.28% |
| 7 August, 2026 | 39.9437 | -0.04% |
| 6 August, 2026 | 39.9592 | -0.06% |
| 5 August, 2026 | 39.9832 | -0.13% |
| 4 August, 2026 | 40.0337 | -0.2% |
| 3 August, 2026 | 40.1138 | 0.82% |
| 31 July, 2026 | 39.7889 | 0.09% |
| 30 July, 2026 | 39.7547 | -0.15% |
| 29 July, 2026 | 39.8163 | 0.97% |
| 28 July, 2026 | 39.4330 | 0.09% |
| 27 July, 2026 | 39.3993 | 1.26% |
| 24 July, 2026 | 38.9085 | -0.18% |
| 23 July, 2026 | 38.9805 | -0.51% |
| 22 July, 2026 | 39.1819 | -0.66% |
| 21 July, 2026 | 39.4414 | 0.37% |
| 20 July, 2026 | 39.2946 | 0.83% |
| 17 July, 2026 | 38.9711 | -0.91% |
| 16 July, 2026 | 39.3274 | 0.27% |
| 15 July, 2026 | 39.2197 | 0.21% |
| 14 July, 2026 | 39.1382 | 0.51% |
| 13 July, 2026 | 38.9403 |
FAQ (Frequently asked questions)
What is latest/current NAV/price of Tata India Pharma & Healthcare Fund-Direct Plan-Growth?
The latest NAV of Tata India Pharma & Healthcare Fund-Direct Plan-Growth is 39.7376 as on 21 August, 2026.What are YTD (year to date) returns of Tata India Pharma & Healthcare Fund-Direct Plan-Growth?
The YTD (year to date) returns of Tata India Pharma & Healthcare Fund-Direct Plan-Growth are 12.49% as on 21 August, 2026.What are 1 year returns of Tata India Pharma & Healthcare Fund-Direct Plan-Growth?
The 1 year returns of Tata India Pharma & Healthcare Fund-Direct Plan-Growth are 9.32% as on 21 August, 2026.What are 3 year CAGR returns of Tata India Pharma & Healthcare Fund-Direct Plan-Growth?
The 3 year annualized returns (CAGR) of Tata India Pharma & Healthcare Fund-Direct Plan-Growth are 20.22% as on 21 August, 2026.What are 5 year CAGR returns of Tata India Pharma & Healthcare Fund-Direct Plan-Growth?
The 5 year annualized returns (CAGR) of Tata India Pharma & Healthcare Fund-Direct Plan-Growth are 15.48% as on 21 August, 2026.What are 10 year CAGR returns of Tata India Pharma & Healthcare Fund-Direct Plan-Growth?
The 10 year annualized returns (CAGR) of Tata India Pharma & Healthcare Fund-Direct Plan-Growth are 15.48% as on 21 August, 2026.